AnserBio
Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -
StartupAnserBio is a Nesher-based startup in the Health Tech & Life Sciences sector, established in 2017. Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. - . The company has raised a total of $6.45M across 6 funding rounds, currently at the Seed stage. AnserBio was founded by Lana Volokh and Dr. Alex Tendler. Key investors include Peregrine Ventures, Israel Biotech Fund, ExitValley. The company has 1-10 employees. Core technologies: Materials & Substances, Nanomaterials, Biologicals, Cells.
With $6.45M in total funding, AnserBio is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQNesher
- DistrictNorth District
- Last Round$4M
- Peregrine Ventures
- Israel Biotech FundLead
- ExitValleyLead
Lana VolokhCo-founder & CEO
Dr. Alex TendlerCo-founder & CTO
1 article covered by sources including en.globes.co.il.
What does AnserBio do?
AnserBio (previously ExoProTher Medical) is a biomedical start-up developing a novel approach to cancer treatment. The company targets the p53-based tumor suppression mechanism that is mutated in over 60% of cancers, including glioblastoma, colon, bladder, ovarian, and small cell lung cancers. It uses proprietary cell derived nano-particles to deliver healthy p53 and restore the body's natural tumor suppression function with minimal adverse side effects. The company is in the preclinical stage.
How much funding has AnserBio raised?
AnserBio has raised $6.45M in total funding across 6 rounds. The company is currently at the Seed stage. Key investors include Peregrine Ventures, Israel Biotech Fund, ExitValley.
Who founded AnserBio?
AnserBio was founded in 2017 by Lana Volokh (Co-founder & CEO), Dr. Alex Tendler (Co-founder & CTO).
What sector is AnserBio in?
AnserBio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Materials & Substances, Nanomaterials, Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is AnserBio located?
AnserBio is based in HaTa'asiya St, Nesher, Israel, North District.